Eshmun Biotech Private Limited
About Eshmun Biotech Private Limited
Data last updated:
Eshmun Biotech Private Limited is a private limited company based in Bathinda, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2015PTC039516. Its GSTIN is 03AAECE1396G1ZV (Punjab).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Parshotam Dass and Umesh Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E75 Growth Center, Bathinda, Punjab, India – 151001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.77 Cr, a growth of 68% compared to the previous year. For the same year it recorded a net profit of ₹14.02 Lakh (net margin 2.1%) and EBITDA of ₹38.83 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 32% over five years.
As per MCA filings, the company has open charges of ₹47 Lakh on record. Court records list 10 cases involving the company, including 8 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE75 Growth Center, Bathinda, Punjab, India – 151001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Eshmun Biotech Private Limited
The main business activity of Eshmun Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Eshmun Biotech Private Limited FY 2025 filings available
Eshmun Biotech Private Limited reported revenue of ₹6.77 Cr (up 68% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Eshmun Biotech Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 68% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Eshmun Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹38.83 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14.02 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Eshmun Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Eshmun Biotech are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Eshmun Biotech Private Limited
Eshmun Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beid Healthcare Private Limited | ₹6.81 Cr (FY 2024) | •••• | •••• | -77.0% | •••• | Navi Mumbai, Maharashtra, India |
| Estragen Pharma Private Limited | ₹6.8 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Jaipur, Rajasthan, India |
| Pharmachem Biotech (I) Private Limited | ₹6.79 Cr (FY 2025) | •••• | •••• | 72.0% | •••• | Mumbai, Maharashtra, India |
| Care Tech Life Science Private Limited | ₹6.78 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Bangalore, Karnataka, India |
| Gliesse Pharmaceuticals Private Limited | ₹6.78 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Ahmedabad, Gujarat, India |
| Eshmun Biotech Private Limited this company | ₹6.77 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Bathinda, Punjab, India |
| Aingo Pharma Private Limited | ₹6.77 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Manimajra, Chandigarh, India |
| Sanora Pharmaceuticals Private Limited | ₹6.77 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Ambitree India Private Limited | ₹6.75 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Delhi, India |
| Biomade Life Care Private Limited | ₹6.74 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Mohali, Punjab, India |
| Dermarex Health Care India Private Limited | ₹6.74 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Coimbatore, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Eshmun Biotech by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Eshmun Biotech Private Limited
Eshmun Biotech Private Limited is audited by PRAKASHSACHIN&CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRAKASHSACHIN&CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Eshmun Biotech Private Limited
Eshmun Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parshotam Dass | Director | 05 Jun 2015 | 11 Years 4 Months | Current |
| Umesh Mehta | Director | 05 Jun 2015 | 11 Years 4 Months | Current |
Ownership and Shareholding of Eshmun Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Eshmun Biotech Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2016 | Dena Bank | ₹47 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Eshmun Biotech Private Limited
Eshmun Biotech Private Limited has 10 court cases on record: 8 filed by Eshmun Biotech, 1 filed against it, 1 where it is another party. All cases are disposed. Status as checked between 01 Oct 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 0 | 0 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Company is another party | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Curewell Drugs & Pharmaceuticals Pvt. Ltd | Disposed |
| District court, Bathinda, Punjab | Commercial suit | Filed by the company against an individual | Disposed |
| District court, Bathinda, Punjab | Commercial suit | Filed by the company against an individual | Disposed |
| District court, Bathinda, Punjab | Commercial suit | Filed by the company against an individual | Disposed |
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Eshmun Biotech Private Limited
Employment history and EPFO contributions of people linked to Eshmun Biotech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Eshmun Biotech Private Limited
Eshmun Biotech Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Ramesh Kumar Behal ceased to be Director on 10 Feb 2020.
Credit Ratings, Litigation & Regulatory Alerts for Eshmun Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Eshmun Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Eshmun Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Eshmun Biotech Private Limited
Eshmun Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAECE1396G1ZV | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Eshmun Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eshmun Biotech Private Limited
Eshmun Biotech is an active private limited company based in Bathinda, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 June 2015 (11+ years old) and is registered under CIN U24232PB2015PTC039516.
Eshmun Biotech reported revenue of ₹6.77 Cr for FY 2025 (up 68% YoY).
Eshmun Biotech has 2 current directors:
- Parshotam Dass - Director
- Umesh Mehta - Director
Eshmun Biotech reported a net profit of ₹14.02 Lakh (net margin 2.1%) and EBITDA of ₹38.83 Lakh (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Eshmun Biotech is 24% over three years and 32% over five years. In the latest year (FY 2025) revenue rose 68%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Eshmun Biotech is 03AAECE1396G1ZV, registered in Punjab.
The CIN (Corporate Identification Number) of Eshmun Biotech is U24232PB2015PTC039516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eshmun Biotech has 10 court cases on record: 8 filed by the company and 1 filed against it. Most are in the district courts.
Eshmun Biotech was incorporated on 05 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Eshmun Biotech by revenue are Beid Healthcare Private Limited, Estragen Pharma Private Limited, Pharmachem Biotech (I) Private Limited, Care Tech Life Science Private Limited, Gliesse Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Ramesh Kumar Behal ceased to be Director on 10 Feb 2020. Ravi Goyal ceased to be Director on 27 Jul 2019. Parshotam Dass was appointed as Director on 05 Jun 2015. Eshmun Biotech has 4 board changes on record in total.